<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Ilaria Capriolo on Medium]]></title>
        <description><![CDATA[Stories by Ilaria Capriolo on Medium]]></description>
        <link>https://medium.com/@capriolo.ilaria?source=rss-bc8915963944------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*UI75czOMYeB1TavRwFAYkA.jpeg</url>
            <title>Stories by Ilaria Capriolo on Medium</title>
            <link>https://medium.com/@capriolo.ilaria?source=rss-bc8915963944------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 21:30:52 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@capriolo.ilaria/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Oltre 200 rifiuti e continuo a costruire: cerco la mia prima opportunità nel Science Writing (anche…]]></title>
            <link>https://medium.com/@capriolo.ilaria/oltre-200-rifiuti-e-continuo-a-costruire-cerco-la-mia-prima-opportunit%C3%A0-nel-science-writing-anche-625f89349ecd?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/625f89349ecd</guid>
            <category><![CDATA[offerte-lavoro]]></category>
            <category><![CDATA[medium-italia]]></category>
            <category><![CDATA[italiano]]></category>
            <category><![CDATA[lavoro]]></category>
            <category><![CDATA[remote-working]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Sun, 22 Nov 2026 00:19:59 GMT</pubDate>
            <atom:updated>2026-11-22T00:19:59.623Z</atom:updated>
            <content:encoded><![CDATA[<h3>Oltre 200 rifiuti e continuo a costruire: cerco la mia prima opportunità nel Science Writing (anche un progetto di 1 mese)</h3><h3>A settembre 2025 ho iniziato a cercare lavoro. Da allora ho inviato più di 200 candidature, anche per posizioni entry-level che non richiedevano alcuna esperienza. Il risultato? Per lo più silenzio, rifiuti automatici e qualche truffa lungo il percorso.<br>Sarebbe facile trasformare questo post in uno sfogo su quanto sia rotto il sistema di selezione. Invece, voglio essere trasparente su dove mi trovo, su ciò che so fare concretamente e sul tipo esatto di opportunità che sto cercando in questo momento.</h3><h3>Il mio percorso (senza giri di parole)</h3><p>Non ho seguito un percorso lineare tradizionale. Dopo aver conseguito il diploma tecnico in biotecnologie sanitarie, ho provato a vivere della mia arte. Non ha funzionato e ho dovuto cambiare direzione.</p><p>A giugno 2026 ho deciso di costruirmi una carriera nella scrittura e nell’editing scientifico e medico. Non ho ancora un dottorato o anni di esperienza in agenzia, quindi ho iniziato a fare l’unica cosa sotto il mio controllo: studiare, formarmi e produrre contenuti ogni singolo giorno.</p><h3>Ecco cosa sto facendo attivamente in questo momento:</h3><p>• Scrittura e traduzione scientifica: Ogni settimana faccio ricerca, scrivo e adatto articoli scientifici e medici in inglese, italiano e spagnolo proprio qui su Medium.<br>• Supporto concreto alla ricerca: Faccio volontariato con Cochrane Crowd, occupandomi dello screening e della classificazione dei dati degli studi clinici a supporto della medicina basata sulle evidenze.<br>• Annotazione di dati per l’IA: Ho completato i primi incarichi come AI Trainer su Prolific.<br>• Formazione continua: Ho conseguito certificazioni in ICH GCP E6(R3), Peer Review (Nature Masterclasses) e Ricerca Clinica.</p><h3>Cosa sto cercando (e perché sono pronta a iniziare oggi)</h3><p>A causa di problemi di salute ancora in corso — che migliorano giorno dopo giorno, ma che richiedono comunque di gestire le mie energie con attenzione — cerco esclusivamente ruoli in full-remote. Lavorare da remoto non è solo una preferenza per me: è l’ambiente in cui sono più disciplinata, autonoma e affidabile con le scadenze.<br>Voglio essere chiara fin da subito anche sull’aspetto burocratico: vivendo in Italia, aprire una Partita IVA senza una base stabile di clienti è finanziariamente rischioso.</p><p>Per questo motivo, sto cercando nello specifico:<br>• Contratti di lavoro a breve termine o a tempo determinato (anche solo da 1 a 3 mesi per aiutare il vostro team a smaltire il lavoro arretrato)<br>• Contratti di collaborazione a progetto (come i contratti co.co.co. in Italia)<br>• Stage retribuiti o posizioni entry-level da remoto</p><h3>Come posso aiutare il vostro team</h3><p>Se gestite una pubblicazione scientifica, una startup health-tech, un progetto di ricerca o un’agenzia di contenuti, posso entrare subito in azione per aiutarvi con:<br>• Stesura o semplificazione di contenuti complessi in ambito biotech e sanitario per un pubblico generale<br>• Traduzione e localizzazione di articoli scientifici tra italiano, spagnolo e inglese<br>• Screening della letteratura, annotazione di dati o supporto editoriale</p><p>Se avete un progetto a breve termine, un picco di lavoro temporaneo o una posizione entry-level aperta — e siete disposti a dare un’opportunità a una writer determinata e veloce nell’apprendere — mi farebbe molto piacere mettermi in contatto con voi.<br>Potete scrivermi a workwith.Capriolo.Ilaria@gmail.com</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=625f89349ecd" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Más de 200 rechazos y sigo construyendo: busco mi primera oportunidad en redacción científica…]]></title>
            <link>https://medium.com/@capriolo.ilaria/m%C3%A1s-de-200-rechazos-y-sigo-construyendo-busco-mi-primera-oportunidad-en-redacci%C3%B3n-cient%C3%ADfica-2ce7d898d0fa?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/2ce7d898d0fa</guid>
            <category><![CDATA[escritura]]></category>
            <category><![CDATA[trabajo-remoto]]></category>
            <category><![CDATA[trabajo]]></category>
            <category><![CDATA[medium-en-español]]></category>
            <category><![CDATA[español]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Sun, 22 Nov 2026 00:15:40 GMT</pubDate>
            <atom:updated>2026-11-22T00:15:40.648Z</atom:updated>
            <content:encoded><![CDATA[<h3>Más de 200 rechazos y sigo construyendo: busco mi primera oportunidad en redacción científica (incluso un proyecto de 1 mes)</h3><h3>En septiembre de 2025 empecé a buscar trabajo. Desde entonces, he enviado más de 200 candidaturas, incluso para puestos de nivel inicial que no requerían experiencia previa. ¿El resultado? En su mayoría silencio, rechazos automáticos y algunas estafas por el camino.<br>Sería fácil convertir esta publicación en una queja sobre lo roto que está el sistema de selección. En cambio, quiero ser transparente sobre dónde estoy, lo que realmente sé hacer y el tipo exacto de oportunidad que busco ahora mismo.</h3><h3>Mi trayectoria (sin rodeos)</h3><p>No seguí un camino lineal tradicional. Tras obtener mi título técnico en biotecnología sanitaria, intenté vivir de mi arte. No funcionó y tuve que dar un giro a mi carrera.<br>En junio de 2026 decidí construirme un futuro en la redacción y edición científica y médica. Todavía no tengo un doctorado ni años de experiencia en agencia, así que empecé a hacer lo único que estaba bajo mi control: estudiar, formarme y producir contenido cada día.</p><h3>Esto es lo que estoy haciendo activamente ahora mismo</h3><p>• Redacción y traducción científica: Cada semana investigo, escribo y adapto artículos científicos y de salud en inglés, italiano y español aquí mismo en Medium.<br>• Apoyo práctico a la investigación: Colaboro como voluntaria en Cochrane Crowd, clasificando y revisando datos de ensayos clínicos para apoyar la medicina basada en la evidencia.<br>• Anotación de datos para IA: He completado mis primeras tareas como AI Trainer en Prolific.<br>• Formación continua: He completado cursos certificados en ICH GCP E6(R3), Revisión por Pares (Nature Masterclasses) e Investigación Clínica.</p><h3>Qué busco (y por qué estoy lista para empezar hoy)</h3><p>Debido a problemas de salud actuales —que mejoran día a día, aunque todavía me exigen gestionar mi energía con cuidado— busco exclusivamente puestos 100 % en remoto. Trabajar a distancia no es solo una preferencia para mí: es el entorno en el que soy más disciplinada, autónoma y fiable con los plazos de entrega.<br>También quiero ser clara desde el principio respecto a la burocracia: al residir en Italia, darme de alta como autónoma (Partita IVA) sin una base estable de clientes es financieramente arriesgado.</p><p>Por ello, busco específicamente:<br>• Contratos laborales de corta duración o temporales (incluso de 1 a 3 meses para ayudar a vuestro equipo a sacar adelante trabajo acumulado)<br>• Contratos de colaboración por proyecto (como los acuerdos italianos co.co.co.)<br>• Prácticas remuneradas o puestos de nivel inicial en remoto</p><h3>Cómo puedo ayudar a vuestro equipo</h3><p>Si diriges una publicación científica, una startup de tecnología sanitaria (health-tech), un proyecto de investigación o una agencia de contenidos, puedo incorporarme de inmediato para ayudar con:<br>• Redacción o simplificación de contenidos complejos de biotecnología y salud para un público general<br>• Traducción y localización de artículos científicos entre italiano, español e inglés<br>• Cribado de literatura científica, anotación de datos o apoyo editorial</p><p>Si tienes un proyecto a corto plazo, un pico puntual de trabajo o una vacante de nivel inicial —y estás dispuesto a darle una oportunidad a una redactora determinada y que aprende rápido— me encantaría conectar.<br>Puedes escribirme a workwith.Capriolo.Ilaria@gmail.com</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2ce7d898d0fa" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[200+ Rejections and Still Building: Looking for My First Shot in Science Writing (Even a 1-Month…]]></title>
            <link>https://medium.com/@capriolo.ilaria/200-rejections-and-still-building-looking-for-my-first-shot-in-science-writing-even-a-1-month-64f37b334e8e?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/64f37b334e8e</guid>
            <category><![CDATA[job-search]]></category>
            <category><![CDATA[writer]]></category>
            <category><![CDATA[text-editor]]></category>
            <category><![CDATA[job-hunting]]></category>
            <category><![CDATA[science]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Sun, 22 Nov 2026 00:02:01 GMT</pubDate>
            <atom:updated>2026-11-22T00:09:13.235Z</atom:updated>
            <content:encoded><![CDATA[<h3>200+ Rejections and Still Building: Looking for My First Shot in Science Writing (Even a 1-Month Gig)</h3><h3>In September 2025, I started looking for a job. Since then, I have sent over 200 applications—even for entry-level roles requiring zero experience. The result? Mostly silence, automated rejections, and a few scams along the way.<br>It would be easy to turn this post into a rant about how broken the hiring process is. Instead, I want to be transparent about where I am, what I can actually do, and the exact kind of opportunity I am looking for right now.</h3><h3>My Background (Without the Fluff)</h3><p>I didn’t take a traditional linear path. After earning my technical diploma in sanitary biotechnology, I tried to make a living through my art. It didn’t work out, and I had to pivot.<br>In June 2026, I decided to build a career in science and medical writing/editing. I don’t have a PhD or years of agency experience yet, so I started doing the only thing under my control: studying, training, and producing work every single day.</p><h3>Here is what I am actively doing right now</h3><p>• Writing and translating science: Every week, I research, write, and adapt scientific and healthcare articles into English, Italian, and Spanish right here on Medium.<br>• Hands-on research support: I volunteer with Cochrane Crowd, screening and classifying clinical trial data to support evidence-based medicine.<br>• AI data annotation: I’ve completed initial tasks as an AI Trainer on Prolific.<br>• Continuous training: I’ve completed certified courses in ICH GCP E6(R3), Peer Review (Nature Masterclasses), and Clinical Research.</p><h3>What I Am Looking For (And Why I’m Ready to Start Today)</h3><p>Because of ongoing health challenges—which are improving day by day, though they still require me to manage my energy carefully—I am looking exclusively for full-remote roles. Working remotely isn’t just a preference for me; it is the environment where I am most disciplined, autonomous, and reliable with deadlines.</p><p>I also want to be upfront about bureaucracy: being based in Italy, opening a VAT number (Partita IVA) without a steady client base is financially risky. Because of this, I am specifically looking for:<br>• Short-term or fixed-term employment contracts (even just 1 to 3 months to help your team clear a backlog)<br>• Project-based collaboration contracts (such as Italian co.co.co. agreements)<br>• Paid internships or entry-level remote roles</p><h3>How I Can Help Your Team</h3><p>If you run a science publication, a health-tech startup, a research project, or a content agency, I can jump in immediately to help with:<br>• Drafting or simplifying complex biotech and healthcare content for a general audience<br>• Translating and localizing scientific articles across Italian, Spanish, and English<br>• Literature screening, data annotation, or editorial support</p><p>If you have a short-term project, a temporary bottleneck, or an entry-level opening—and you’re willing to give a determined, fast-learning writer a shot—I’d love to connect.<br>You can reach me at workwith.Capriolo.Ilaria@gmail.com</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=64f37b334e8e" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[My general opinion on ALIENS!!!]]></title>
            <link>https://medium.com/@capriolo.ilaria/my-general-opinion-on-aliens-be984cec48df?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/be984cec48df</guid>
            <category><![CDATA[aliens]]></category>
            <category><![CDATA[kardashev-scale]]></category>
            <category><![CDATA[speculation]]></category>
            <category><![CDATA[physics]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Tue, 17 Nov 2026 09:01:02 GMT</pubDate>
            <atom:updated>2026-11-17T09:01:02.373Z</atom:updated>
            <content:encoded><![CDATA[<p>Hi!!! It’s Ilaria here and this article DOESN’T aim to force my thoughts on you.</p><blockquote><strong>“THEY MEAN NO HARM.”</strong></blockquote><p>Aliens, who are able to make any type of contact through astronomical distances, are beings deprived of negative traits!</p><p>I truly believe in this statement because if they were like us, negatively inclined, they would have already gone extinct even before becoming a Type I civilization on the Kardašëv scale. Right after or in a little time after discovering atomic and nuclear technology (centuries, not years), their stupid wars would have led to extinction and even the destruction of their planet. This period of a civilization, the Great Filter, is pretty important to its survival; it can either destroy itself or develop.</p><p>In my opinion those beings can make mistakes and damage us, but always without the intention to do so; they think it is the right thing to do. <em>No one in this universe is infallible; what an utopian statement it would be!!!</em></p><blockquote><strong>“TECHNOLOGICAL THOUGHTS.”</strong></blockquote><p>I think that maybe they have found a way to eradicate any disease, for example by genetic modification.</p><p>I even think they have found a less polluting and complex way to take in nutrients, for example developing a photosynthetic ability or pills containing all the necessary supplements that need to be taken just once a day.</p><p>Maybe they have found even a way to develop a technology that enables them to change form or become invisible?!?</p><p>Previously in this article I mentioned Kardašëv scale, let me introduce this theory to you.↙️</p><p>Kardašëv introduced this scale in 1964 in order to describe civilizations depending on how much energy they are able to use:</p><ul><li>Type I civilization: exploits and manages all useful energy from its own planet;</li><li>Type II civilization: exploits and manages all useful energy from its own star;</li><li>Type III civilization: exploits and manages all useful energy from its own galaxy, including black holes.</li></ul><p>On Kardašëv scale our civilization is at 0.72.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/0*MHyDN_-7-lLR4_93" /><figcaption>from SETI Institute</figcaption></figure><p>Over the last 20 years some scientists and science-fiction writers proposed 2 more types of civilizations. This update is based on speculations:</p><ul><li>Type IV civilization: exploits and manages all useful energy from the visible universe;</li><li>Type V civilization: exploits and manages all useful energy from the multiverse.</li></ul><blockquote><strong>“HOW DO THEY LOOK?”</strong></blockquote><p>Someone pictures them as humanoids or like monsters, but personally I am not able to give them any sort of form.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*6RT7ud3uSltQlZHi" /><figcaption>Photo by <a href="https://unsplash.com/@theshuttervision?utm_source=medium&amp;utm_medium=referral">Jonathan Cooper</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><blockquote><strong>“THEIR FINAL AIM WITH US.”</strong></blockquote><p>To study us in order to improve their knowledge and simply to help.</p><p>So thrilled to read your opinions on this topic!!! Write them in the comments💖.</p><p>Article written by Capriolo Ilaria.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=be984cec48df" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[La mia generale opinione sugli ALIENI!!!]]></title>
            <link>https://medium.com/@capriolo.ilaria/la-mia-generale-opinione-sugli-alieni-41930548ee15?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/41930548ee15</guid>
            <category><![CDATA[speculation]]></category>
            <category><![CDATA[italiano]]></category>
            <category><![CDATA[kardashev-scale]]></category>
            <category><![CDATA[medium-italiano]]></category>
            <category><![CDATA[aliens]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Tue, 10 Nov 2026 09:01:02 GMT</pubDate>
            <atom:updated>2026-11-10T09:01:02.530Z</atom:updated>
            <content:encoded><![CDATA[<p>Ciao!!! Sono Ilaria e questo articolo NON ha il fine di imporre il mio pensiero a nessuno.</p><blockquote><strong>“VENGONO IN PACE.”</strong></blockquote><p>Gli alieni, in grado di mettersi in contatto attraverso distanze astronomiche, sono degli esseri privi di tratti negativi!</p><p>Credo fermamente in questa mia affermazione perché se fossero come noi, quindi tendenti al negativo, si sarebbero già estinti prim’ancora di arrivare ad una civiltà di tipo I, della scala di Kardašëv; se avessero avuto tratti negativi, appena o poco dopo aver scoperto l’atomico e il nucleare (ipotizzo secoli e non anni), le loro stupide guerre avrebbero portato alla distruzione della loro intera razza, e forse anche del loro pianeta. Questo momento della storia di una civiltà, il Grande Filtro, è ritenuto fondamentale per la sua sopravvivenza, dato che può sia autodistruggersi sia fare il grande salto.</p><p>Secondo me sono degli esseri che possono commettere errori e danni nei confronti di altri esseri viventi, ma mai volontariamente; lo fanno perché pensano, nel limite delle loro conoscienze, che ciò sia la cosa giusta da fare. <em>Nessuno in questo universo è infallibile, sarebbe un’utopia!!!</em></p><p>Hanno elevato così tanto la loro coscenza, rispetto a noi, che i problemi, per noi insormontabili, sono insignificanti (in primo luogo neanche sorgono).</p><blockquote><strong>“PENSIERI TECNOLOGICI.”</strong></blockquote><p>Immagino che abbiano trovato un modo per eliminare ogni tipo di malattia, come ad esempio modificandosi a livello genetico.</p><p>Immagino che abbiano trovato un modo meno inquinante e macchinoso per assumere i nutrienti necessari, ad esempio sviluppando una capacità fotosintetica o l’ideazione di una pillola contenente tutto il necessario e da assumere una sola volta al giorno.</p><p>Potrebbero aver anche sviluppato una tecnologia in grado di farli mutare forma o renderli invisibili?!?</p><p>Prima ho nominato la scala di Kardašëv, lasciatemi raccontare questa bella teoria.↙️</p><p>Kardašëv ha introdotto questa scala nel 1964 per descrivere le civiltà in base alla quantità di energia che sono in grado di utilizzare:</p><ul><li>Civiltà di tipo I: sfrutta e gestisce tutta l’energia ricavabile dal proprio pianeta;</li><li>Civiltà di tipo II: sfrutta e gestisce tutta l’energia ricavabile dalla propria stella;</li><li>Civiltà di tipo III: sfrutta e gestisce tutta l’energia ricavabile dalla propria galassia, inclusi i buchi neri.</li></ul><p>Secondo stime astrofisiche attuali, nel caso della nostra civiltà siamo al valore di circa 0.72 della scala di Kardašëv.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/640/0*EhcZLWXmP8Zxnh0z.jpg" /></figure><p>Nell’ultimo ventennio alcuni scienziati e scrittori di fantascienza hanno proposto un’estensione di questa scala. Basandosi su speculazioni hanno introdotto:</p><ul><li>Civiltà di tipo IV: sfrutta e gestisce tutta l’energia ricavabile dall’universo osservabile;</li><li>Civiltà di tipo V: sfrutta e gestisce tutta l’energia ricavabile da molteplici universi paralleli.</li></ul><blockquote><strong>“COME CREDO SIANO LE LORO FATTEZZE.”</strong></blockquote><p>Molti li immaginano umanoidi o mostruosi, ma io sinceramente non riesco a dar loro una forma.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*6RT7ud3uSltQlZHi" /><figcaption>Photo by <a href="https://unsplash.com/@theshuttervision?utm_source=medium&amp;utm_medium=referral">Jonathan Cooper</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><blockquote><strong>“IL LORO OBIETTIVO FINALE CON NOI.”</strong></blockquote><p>Studiarci per ampliare la loro conoscenza e aiutarci.</p><p>Sono troppo curiosa delle vostre opinioni, quindi scrivetemele pure nei commenti 💖.</p><p>Articolo scritto da Capriolo Ilaria.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=41930548ee15" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[NERVE GROWTH FACTOR]]></title>
            <link>https://medium.com/@capriolo.ilaria/nerve-growth-factor-9d56197c9612?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/9d56197c9612</guid>
            <category><![CDATA[ngf]]></category>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[neurobiology]]></category>
            <category><![CDATA[nervous-system]]></category>
            <category><![CDATA[rita-levi-montalcini]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Wed, 04 Nov 2026 09:11:01 GMT</pubDate>
            <atom:updated>2026-11-04T09:11:01.517Z</atom:updated>
            <content:encoded><![CDATA[<p>Hi this is Ilaria and today I’ll make this ⬆️ simple!!!</p><p>In the early 80s genetics engineer provided the knowledge to identify the genes involved in the production of the NGF; these ones were found in different species.</p><p>Hypothesis pre-80s :</p><ul><li>Scientist thought that its action was related just to the PNS, peripheral nervous system (which comprehends everything except the brain and the spinal cord); so not as for vitamins and hormones which ones were already known to be related to a lot more systems in the organism.</li></ul><blockquote><strong>DISCOVERIES!</strong></blockquote><ol><li>NGF was discovered to have a role in other fields too: adrenal glands, hypothalamus, pituitary gland, numerous immunological-inflammatory conditions, neurodegenerative diseases, conditions involving increased sensitivity to pain, skin disorders, and many other cases.</li><li>This factor was discovered to have the ability to block the programmed cell death (because cells are too old). The block of this process, known as apoptosis, means there is a proliferation (so more than we need of) of cells, leading to neoplasms (tumors). It is one of the active tumoral components and a little after 1954 was finally named <em>nerve growth factor</em>.</li><li>It was discovered to be able to guide the nerve fibers growth path, thanks to specifics biological processes.</li><li>It was discovered to be able to decide in which type the cells would develop (whether epithelial, nervous, endocrine, exocrine, etc…).</li></ol><blockquote><strong>ITS STRUCTURE</strong></blockquote><p>It was 1972 when Ruth Hogue Angeletti and Ralph Bradshaw described its structure for the first time.</p><p>It is pretty simple: 2 polypeptide chains of 118 amino acids each.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/260/0*xJLiFrm_-OcFM9_a.jpg" /></figure><p>In the early 80s the NGF gene, which encoded for the NGF precursor, was localized in the chromosome one.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/250/0*FAORriyZYwU_L9iE" /><figcaption>Da wikipedia</figcaption></figure><blockquote><strong>How do we induce its overproduction?</strong></blockquote><p>We do so through specific biological, environmental and behavioural signals:</p><ul><li>As a response to a damaged tissue (like a cut);</li><li>As a response to the immune system (like a bacterial infection);</li><li>As a response to hormones and metabolism (like the malfunction of the thyroid);</li><li>As a response to behaviour (like the use of drugs).</li></ul><blockquote><strong>Lastly, how do we fight it?</strong></blockquote><p>NGF levels can be lowered by using specific therapies.</p><p>Article written by Ilaria Capriolo, using information found in the book “NGF The molecule of life”, published by Treccani, by Rita Levi-Montalcini, with an introduction by Elena Cattaneo in collaboration with Andrea Grinoglio.<br>If this topic has caught your attention, I highly recommend reading the book.</p><p>Rita Levi-Montalcini (1909–2012), neurologist won the 1986 Nobel Prize in Medicine.</p><p>Elena Cattaneo, pharmacologist and biologist.</p><p>Andrea Grinoglio, lecturer in medical humanities and bioethics.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9d56197c9612" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[NERVE GROWTH FACTOR (factor de crecimiento)]]></title>
            <link>https://medium.com/@capriolo.ilaria/nerve-growth-factor-factor-de-crecimiento-e785511012e1?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/e785511012e1</guid>
            <category><![CDATA[español]]></category>
            <category><![CDATA[medicina]]></category>
            <category><![CDATA[medium-en-español]]></category>
            <category><![CDATA[rita-levi-montalcini]]></category>
            <category><![CDATA[ngf]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Wed, 04 Nov 2026 09:06:01 GMT</pubDate>
            <atom:updated>2026-11-04T09:06:01.556Z</atom:updated>
            <content:encoded><![CDATA[<p>Holaaa, soy Ilaria in en este articulo les voy a hacer este tema más simple.</p><p>En los años 80 la ingeniería genética permitió identificar los genes involucrados en la producción de NGF; estos genes fueron encontrados en varias especies.</p><p>Hipótesis pre-años ’80:</p><ul><li>Las informaciones que teníamos nos hacían pensar que su unica acción estaba localizada en el SNP, sistema nervoso periferico (todo menos el cerebro y la médula espinal), a diferencia de las vitaminas y las hormonas que ya se sabían tener uno espectro de acción muy ampio.</li></ul><blockquote><strong>DESCUBRIMIENTOS</strong></blockquote><ol><li>El NGF, y otros factores de crecimiento, están implicados tambien en: glándulas suprarrenales, hipotálamo, glándula hipofisaria, numerosas afecciones inmunológicas e inflamatorias, enfermedades neurodegenerativas, trastornos que llevan a una mayor sensibilidad al dolor, afecciones cutáneas y muchos otros casos.</li><li>Este factor tiene la capacidad de bloquear la muerte célular programada (cuando una célula ya està vieja). El bloque de este proceso, la apoptosis, significa que vamos a tener una proliferación célular (más de la que necesitamos), llevando a la formación de neoplasmas (tumores). En los años 1954 se denominó <em>nerve growth factor.</em></li><li>La capacidad de guiar el camino de crecimiento de las fibras nerviosas, utilizando procesos biologicos precisos.</li><li>La capacidad de elegir en que tipo celular se deben diferenciar las células (si van a ser epiteliales, nerviosas, endocrinas, etc…).</li></ol><blockquote><strong>LA ESTRUCTURA</strong></blockquote><p>Era el 1971 cuando Ruth Hogue Angeletti e Ralph Bradshaw identificaron su estructura.</p><p>Es re simple: 2 cadenas polipeptidicas de 118 aminoácidos cada una.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/260/1*lsHoVeuCOlMqmzbVIfsGjQ.jpeg" /></figure><ul><li>En los años 80 el gen NGF, el cual codifica por el precursor del NGF, fue localizado en el cromosoma 1.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/249/1*rY9U_xgSNDqik-C20AtYyA.jpeg" /></figure><blockquote><strong>Cómo se induce el aumento de producción de NGF?</strong></blockquote><p>Se puede aumentar a traves de especificas señales biologicas, ambientales y comportamentales:</p><ul><li>En respuesta a lesiones y daños del tejido (como un corte);</li><li>con una respuesta inmunitaria (como una gripe);</li><li>con una respuesta hormonal/metabolica (como la tiroides que no funciona);</li><li>con una respuesta comportamental (como el uso de alcohol o droga).</li></ul><blockquote><strong>Cómo se puede parar todo esto?</strong></blockquote><p>Simplemente haciendo una terapia con medicamentos especifico.</p><p>Articulo escrito por Capriolo Ilaria con las informaciones tomadas en el libro “NGF La molecula de la vida”, edición Treccani, de Rita Levi-Montalcini y con la introducción de Elena Cattaneo en collaboración con Andrea Grinoglio.</p><p>Les recomiendo leer el libro por completo.</p><p>Rita Levi-Montalcini (1909–2012), neurologa, premio Nobel por la medicina año 1986.</p><p>Elena Cattaneo, farmacóloga y bióloga.</p><p>Andrea Grinoglio, enseña medical humanities y bioética.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e785511012e1" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[NERVE GROWTH FACTOR (fattore di crescita nervoso)]]></title>
            <link>https://medium.com/@capriolo.ilaria/nerve-growth-factor-fattore-di-crescita-nervoso-8aade5b3ebe3?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/8aade5b3ebe3</guid>
            <category><![CDATA[medicina]]></category>
            <category><![CDATA[rita-levi-montalcini]]></category>
            <category><![CDATA[ngf]]></category>
            <category><![CDATA[medium-italia]]></category>
            <category><![CDATA[italiano]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Tue, 03 Nov 2026 09:01:02 GMT</pubDate>
            <atom:updated>2026-11-03T09:01:02.731Z</atom:updated>
            <content:encoded><![CDATA[<p>Ciaoo!!! Sono ilaria e oggi vi rendo accessibile il⬆️.</p><p>Negli anni ’80 l’ingegneria genetica ha permesso di identificare i geni implicati nella produzione del NGF; questi ultimi sono stati riscontrati in diverse specie.</p><p>Ipotesi pre-anni ‘80:</p><ul><li>Si pensava che la sua azione riguardasse solo il SNP, sistema nervoso periferico ( quindi in generale tutto tranne il cervello e il midollo spinale), non come le vitamine e gli ormoni che già si sapeva agissero su svariati sistemi dell’organismo.</li></ul><blockquote><strong>SCOPERTE!</strong></blockquote><ol><li>Il NGF e fattori di crescita anloghi sono stati scoperti avere ruolo anche in: ghiandole surrenali, ipotalamo, ipofisi, numerose patologie immunologiche-infiammatorie, malattiee neurodegenerative, patologie di aumento della sensibilità al dolore, patologie della pelle e tanti altri casi.</li><li>Questo fattore è stato scoperto avere la capacità di bloccare la morte cellulare programmata (cioè per invecchiamento). Il blocco di quest’ultima, nonchè l’apoptosi, equivale alla proliferazione (cioè più di quante dovrebbero esserci) delle cellule, portando così alla formazione di neoplasie (tumori). E’ una delle componenti tumorali attive e poco dopo il 1954 viene finalmente denominata <em>nerve growth factor</em>.</li><li>E’ stato scoperto essere in grado di guidare il percorso di crescita delle fibre nervose, tramite processi biologici precisi.</li><li>E’ stato scoperto essere in grado di scegliere in quale tipo cellulare si debbano differenziare le cellule (se epiteliali, nervose, endocrine, esocrine, etc…).</li></ol><blockquote><strong>LA STRUTTURA</strong></blockquote><p>Nel 1971, da Ruth Hogue Angeletti e Ralph Bradshaw, è stata definita la sua struttura.</p><p>Essa è semplice: 2 catene polipeptidiche da 118 amminoacidi ciascuna.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/260/0*xJLiFrm_-OcFM9_a.jpg" /></figure><p>Negli anni ’80 il gene NGF, il quale codifica per il precursore del NGF, è stato localizzato nel cromosoma 1.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/250/0*FAORriyZYwU_L9iE" /><figcaption>Da wikipedia</figcaption></figure><blockquote><strong>Come viene indotto l’aumento di produzione del NGF?</strong></blockquote><p>Tramite specifici segnali biologici, ambientali e comportamentali:</p><ul><li>In risposta a lesioni/danni ai tessuti (ex. un taglio);</li><li>Come risposta immunitaria (ex. un virus o un batterio);</li><li>Come risposta ormonale/metabolica (ex. la tiroide che non funziona bene);</li><li>Come risposta comportamentale (ex. assunzione di sostanze).</li></ul><blockquote><strong>Infine, come si contrasta l’aumento del NGF?</strong></blockquote><p>Può essere contrastato solo tramite la somministrazione di farmaci specifici.</p><p>Articolo scritto da Capriolo Ilaria con le informazioni prese dal libro “NGF La molecola della vita”, edizione Treccani, di Rita Levi-Montalcini e con l’introduzione di Elena Cattaneo in collaborazione con Andrea Grinoglio.</p><p>Se questo tema vi ha stuzzicato vi consiglio ardentemente di leggervi il libro.</p><p>Rita Levi-Montalcini (1909–2012), neurologa, premio Nobel per la medicina 1986.</p><p>Elena Cattaneo, farmacologa e biologa.</p><p>Andrea Grinoglio, insegna medical humanities e bioetica.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8aade5b3ebe3" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[CASE STUDY | S. aureus + IAV = ?]]></title>
            <link>https://medium.com/@capriolo.ilaria/case-study-s-aureus-iav-762a230962c0?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/762a230962c0</guid>
            <category><![CDATA[case-study]]></category>
            <category><![CDATA[influenza]]></category>
            <category><![CDATA[staphylococcus-aureus]]></category>
            <category><![CDATA[virus]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Wed, 28 Oct 2026 09:16:01 GMT</pubDate>
            <atom:updated>2026-10-28T09:16:01.647Z</atom:updated>
            <content:encoded><![CDATA[<p>Hi, this is Ilaria.</p><p><strong>DISCLAIMER</strong>: this post is an educational editing exercise. The original text analyzed is a preprint called “<em>Staphylococcus aureus</em> enhances influenza A virus replication through modulation of host cell vesicular transport.” by Veerle Appels, Karen Nickel, Elise Therrien, Isabella Schmidt, Lily Sheridan, Megan Vanderwal, Rachel Witt and Mariya I. Goncheva, available on bioRxiv. This analysis is meant purely for training purposes as a science editor.</p><p><strong>A SIMPLIFIED ABSTRACT</strong></p><p>Influenza A virus (IAV) is a pretty dangerous respiratory pathogen that can cause death.</p><p>This study reports how <em>S. aureus</em> helps improve IAV replication through the activity of a surface protein (FnbA).</p><p>This protein is associated with the reduction of the host vesicular trafficking proteins (VPS26A and VTA1); plus, it is also associated with the production and the release of infectious virions.</p><p><strong>MY GOALS</strong></p><p>Verify Data cosistency and APA 7th Edition compliance.</p><p><strong>MY ANALISIS AND HOW I WOULD CORRESCT THE PAPER</strong></p><p>The Abstract:</p><ul><li>The title, as in all the paper too (Discussion, Results, Methods and Materials, Introduction), must be centered, not just in bold;</li><li>It is a compact paragraph;</li><li>It contains a number of words in the acceptable range;</li><li>It is at page 2;</li><li>The page we are at is not shown in the top right corner. It should be like this in all the paper;</li><li>It does not respect, in all the paper too, the line space requested of 2.0 (double);</li><li>Font size is 11.</li></ul><p>The Introduction:</p><ul><li>Not all the first lines, of every paragraph in the paper, are indented correctly (in Discussion, Results, Methods and Materials too).</li></ul><p>Methods &amp; Materials and Results:</p><ul><li>Every Table/Figure “supplementary” is just mentioned; they should be inserted too.</li></ul><p>Discussion:</p><ul><li>Line 404: wrong citation. First of all, the author’s thought mustn’t be interrupted by a page change; secondly, the author + the publication year should be written in brackets (ex. (Smith et al., 2021)) or just with the year in brackets (ex. Smith et al. (2021));</li><li>Every number that’s written after a word and on its top-right corner, must be substituted by author-date system (the one I talked about in the previous point).</li></ul><p>References:</p><ul><li>Must be ordered by alphabetical order instead of mention order.</li></ul><p>Thank you for reading. If you find any mistakes tell me, thanks :)</p><p>Exercise made by Capriolo Ilaria.</p><p>Part of my study.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*VAuP1moXiciRj4a-iM4Pfw.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*MtATV5G-eSOMm5Vm4TyduA.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*edC9Q8g83Scrx9WTJCdgaQ.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-G92JUiJ-1uadJRHWa-wrg.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=762a230962c0" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[CASE STUDY | S. aureus + IAV = ?]]></title>
            <link>https://medium.com/@capriolo.ilaria/case-study-s-aureus-iav-7ea9f9d710e5?source=rss-bc8915963944------2</link>
            <guid isPermaLink="false">https://medium.com/p/7ea9f9d710e5</guid>
            <category><![CDATA[español]]></category>
            <category><![CDATA[medium-en-español]]></category>
            <category><![CDATA[case-study]]></category>
            <category><![CDATA[staphylococcus-aureus]]></category>
            <category><![CDATA[virus]]></category>
            <dc:creator><![CDATA[Ilaria Capriolo]]></dc:creator>
            <pubDate>Wed, 28 Oct 2026 09:06:01 GMT</pubDate>
            <atom:updated>2026-10-28T09:06:01.558Z</atom:updated>
            <content:encoded><![CDATA[<p>Hola, soy Ilaria.</p><p><strong>DISCLAIMER:</strong> Esta publicación es un ejercicio educativo de edición. El texto original analizado es un preprint titulado “<em>Staphylococcus aureus</em> enhances influenza A virus replication through modulation of host cell vesicular transport.” de Veerle Appels, Karen Nickel, Elise Therrien, Isabella Schmidt, Lily Sheridan, Megan Vanderwal, Rachel Witt y Mariya I. Goncheva, disponible en bioRxiv. Este analisis està pensado exclusivamente como entrenamiento, aspiro a ser editor cientifico.</p><p><strong>UN SIMPLE RESUMEN</strong></p><p>El virus de la gripe (IAV) es un patogeno bastante peligroso; puede llevar a la muerte en algunos casos.</p><p>En este estudio se explica como el <em>S. aureus </em>puede ser capaz de aumentar la capacidad de replicación del IAV a travez de la actividad de una proteina de superficie (FnbA).</p><p>Esta proteina està asociada con un numero menor de proteinas vesicular implicadas en el trafico del organismo hospedador ( VPS26A y VTA1); tambien està asociada con la producción y la liberación de viriones infecciosos.</p><p><strong>MI OBJETIVO</strong><br>Verificar la coherencia de los datos y el cumplimiento del estilo APA 7th Edition.</p><p><strong>MI ANALISIS Y COMO CORREGIRIA EL PAPER</strong></p><p>El resumen:</p><ul><li>El titulo debe estar centrado, mas que en negrita; y eso en todo el paper (Discussion, Results, Methods and Materials, Introduction);</li><li>Es un parrafo compacto;</li><li>Las palabras se encuentran en numero aceptable;</li><li>Se encuentra a pagina 2 del paper;</li><li>El numero de la pagina en la que estamos debe escribirse en la esquina derecha de arriba;</li><li>No respeta la interlinea requisida, de 2.0 (doble); y eso en todo el paper;</li><li>la tamaño del la fuente es de 11.</li></ul><p>La introducción:</p><ul><li>No todas las primeras lineas, de cada parrafo, tienen la sangria requerida (tambien en Discussion, Results, Methods and Materials).</li></ul><p>En metodos y materiales y en resultados:</p><ul><li>Cada Tabla/Figura “supplementary” està nominada pero no insertada.</li></ul><p>La discusión:</p><ul><li>Renglón 404: hay una citacion errada. Primero, el pensamiento del autor no se tiene que interrumpir con un cambio de pagina; segundo, el autor tiene que ser nominado entre parentesis + el año de publicación (ejemplo (Garcia et al., 2021)) o solo con el año entre parentesis (ejemplo Garcia et al. (2021));</li><li>Cada numero que està escrito en alto y a la derecha de las palabras tiene que ser sustituido por el sistema autor-año (el del que hablé en el punto anterior).</li></ul><p>Referencias:</p><ul><li>Tienen que ser ordenadas utilizando el orden alfabetico y no utilizando el orden de mencion en el paper.</li></ul><p>Gracias muchisimo por leer.</p><p>Si encuentran algun error, diganmelo y yo lo voy a corregir.</p><p>Ejercicio hecho por Capriolo Ilaria.</p><p>Parte de mi estudio.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*VAuP1moXiciRj4a-iM4Pfw.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*MtATV5G-eSOMm5Vm4TyduA.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*edC9Q8g83Scrx9WTJCdgaQ.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-G92JUiJ-1uadJRHWa-wrg.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=7ea9f9d710e5" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>